SEC Form 4 · accession 0001819879-26-000006
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeanne Thoma
Director
Period of report
Sep 11, 2026
Accepted (ET)
Sep 14, 2026 · 8:57 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 11, 2026 | S | 1,000 | $71.53 | D | 26,762 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2026.